Last edited by iris lilies; 5-9-16 at 8:11pm.
Health care could be a lot less costly if the powers that be, with their hands in the pockets of drug manufacturers and insurance companies, would do the responsible thing and remove profit from the equation. Because of the huge profit margins involved, we pay twice as much as any other country for much poorer outcomes.
People say this sort of thing all the time - "remove profit from the equation".
What does that look like in practice? Who pays for the R&D, trials, approval process, and manufacturing of new drugs, with "profit" removed? Who pays for manufacturing/distribution/litigation costs for existing drugs, with "profit" removed?
Are you envisioning the government stepping in and doing the whole job, or some legislated maximum ROI for this sector, or ...?
I've never quite understood the details. I know what happens when you remove "profit" from the housing market, and it's not pretty. And we see what happens when you remove it from the manufactured-goods and food sectors.
Also, as an investor, which specific pharmaceutical companies and insurance companies have excessive above-market returns, compared to other investment options? I'm always looking for a decent return, but those sectors don't seem strikingly different from others, on average.
I beg to differ. All that media coverage exposed his "weaknesses". The media coverage was a result of people's interest in him. You can't make people watch. And you can't make them believe this or that simply by media coverage. The people drove the coverage. He has a wide following.
The government pays for a lot of the R&D already--which must include the hundreds of slight variations on existing drugs to dodge patent expirations, etc. Drug companies pay more, if I recall correctly, far more, on advertising than they do for R&D. I think non-profit medicine would look a lot like it looked when I was growing up in the ice age before people went bankrupt trying to pay for hospitalizations. And of course all the greedy industries probably started looking alike, return-wise, since the eighties when the "greed is good" philosophy took hold. All hail Martin Shkreli, the patron saint and icon for what medicine has become.
I don't have the figures to back it up, but suspect that a large portion of the new and better drugs come from the U.S. where the profit motive is an large incentive. However, it came as a surprise at least to me that Kaiser and Blue Cross/Blue Shield are not for profit organizations that seem to have made it work, compete in the health care market, grow their market share, and make loads of money and pay giant CEO salaries.
There are currently 2 users browsing this thread. (0 members and 2 guests)